Earnings Feed
Start Free
Home/Filings/4/0001181431-13-063065
4//SEC Filing

Transcept Pharmaceuticals Inc 4

Accession 0001181431-13-063065

CIK 0001178711operating
View on SEC.govCompany Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:01 PM ET

Size

5.8 KB

Accession

0001181431-13-063065

Insider Transaction Report

Form 4
Period: 2013-12-16
Transcept Pharmaceuticals IncTSPT
LOAR MATTHEW M
Director
Transactions
  • Award

    Common Stock (right to buy)

    2013-12-16+25,000→ 25,000 total
    Exercise: $3.30Exp: 2023-12-16→ Common Stock (25,000 underlying)
Holdings

  • Common Stock

    54,755
Footnotes (1)
  • [F1]The option vests in thirty-six equal monthly installments beginning on January 16, 2014.

Documents

1 file

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001178711

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:01 PM ET
Size
5.8 KB
View on SEC.gov